Abstract
Microglia are monocyte-macrophage lineage cells, while other glial cells are neuroectodermal origin. Accumulation of microglia is commonly observed around degenerating neurons. There, microglia produce a variety of factors and function both neurotoxic and neuroprotective. Thus, accumulation of glia in various neurological disorders is not a static scar, gliosis, but more actively involved in degeneration and regeneration as neuroinflammation. We have shown previously that the most neurotoxic factor from activated microglia is glutamate, and that the suppression of glutamate release from microglia results in amelioration of disease progression in animal models of neurodegenerative disorders. On the other hands, when exposed to harmful stimuli, neurons also produce various factors as “help me” signals. Recently, we found that a CX3C chemokine, fractalkine (FKN), and interleukin-34 (IL-34) were secreted from damaged neurons. FKN and IL-34 differently activated microglia to rescue neurons by upregulating phagocytosis of toxicants or damaged debris, and production of anti-oxidant enzyme. The bi-directional interaction between neurons and microglia is important for understanding of chronic neuroinflammation, and gives us clues for future therapeutic strategy against neurodegenerative disorders.
Keywords: Neuron microglia, CNS, Neurodegenerative disorders, ALS
Current Protein & Peptide Science
Title:Neuron-Microglia Interaction in Neuroinflammation
Volume: 14 Issue: 1
Author(s): Akio Suzumura
Affiliation:
Keywords: Neuron microglia, CNS, Neurodegenerative disorders, ALS
Abstract: Microglia are monocyte-macrophage lineage cells, while other glial cells are neuroectodermal origin. Accumulation of microglia is commonly observed around degenerating neurons. There, microglia produce a variety of factors and function both neurotoxic and neuroprotective. Thus, accumulation of glia in various neurological disorders is not a static scar, gliosis, but more actively involved in degeneration and regeneration as neuroinflammation. We have shown previously that the most neurotoxic factor from activated microglia is glutamate, and that the suppression of glutamate release from microglia results in amelioration of disease progression in animal models of neurodegenerative disorders. On the other hands, when exposed to harmful stimuli, neurons also produce various factors as “help me” signals. Recently, we found that a CX3C chemokine, fractalkine (FKN), and interleukin-34 (IL-34) were secreted from damaged neurons. FKN and IL-34 differently activated microglia to rescue neurons by upregulating phagocytosis of toxicants or damaged debris, and production of anti-oxidant enzyme. The bi-directional interaction between neurons and microglia is important for understanding of chronic neuroinflammation, and gives us clues for future therapeutic strategy against neurodegenerative disorders.
Export Options
About this article
Cite this article as:
Suzumura Akio, Neuron-Microglia Interaction in Neuroinflammation, Current Protein & Peptide Science 2013; 14 (1) . https://dx.doi.org/10.2174/1389203711314010004
DOI https://dx.doi.org/10.2174/1389203711314010004 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Multicenter, Double-Blind, Placebo-Controlled Trial of the PDE9A Inhibitor, PF-04447943, in Alzheimer's Disease
Current Alzheimer Research Erythropoietin: A Neuroprotective Agent in Cerebral Hypoxia, Neurodegeneration, and Epilepsy
Current Pharmaceutical Design AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
Current Gene Therapy Ultrasound-Induced Blood-Brain Barrier Opening
Current Pharmaceutical Biotechnology Lipid Raft Alterations in Aged-Associated Neuropathologies
Current Alzheimer Research Recent Advances in the Treatment of Amyotrophic Lateral Sclerosis. Emphasis on Kynurenine Pathway Inhibitors
Central Nervous System Agents in Medicinal Chemistry The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View
Current Alzheimer Research Roles and Therapeutic Potential of Metallothioneins in Neurodegenerative Diseases
Current Pharmaceutical Biotechnology <i>Drosophila melanogaster</i> a Versatile Model of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Current Drug Targets Designing Multi-Targeted Therapeutics for the Treatment of Alzheimer's Disease
Current Topics in Medicinal Chemistry Disease-Modifying Therapies in Frontotemporal Lobar Degeneration
Current Medicinal Chemistry Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation
Recent Patents on CNS Drug Discovery (Discontinued) Past, Present and Future of Nutrigenomics and its Influence on Drug Development
Current Drug Discovery Technologies Intracellular Bioinorganic Chemistry and Cross Talk Among Different -Omics
Current Topics in Medicinal Chemistry Lewy Bodies: A Spectator or Salient Killer?
CNS & Neurological Disorders - Drug Targets Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
Reviews on Recent Clinical Trials Anti-Inflammatory Agents in Parkinsons Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Human PON Promoters: From Similarity to Prediction of Polymorphic Positions within Transcription Factor Elements
Mini-Reviews in Medicinal Chemistry The Role of Mitochondria in Brain Aging and the Effects of Melatonin
Current Neuropharmacology